Stay updated on Niraparib Combo With TSR-042 in Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Niraparib Combo With TSR-042 in Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Niraparib Combo With TSR-042 in Ovarian Cancer Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-13T22:44:10.000Z thumbnail image
  4. Check
    3 days ago
    No Change Detected
  5. Check
    4 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value 7 has recently changed to 8 on the webpage, indicating a potential update or modification in the study details related to the safety and tolerability testing of various combination therapies in patients with advanced or metastatic cancer.
    Difference
    0.1%
    Check dated 2024-06-06T14:37:35.000Z thumbnail image
  7. Check
    16 days ago
    Change Detected
    Summary
    The value (Estimated) on the webpage has recently changed to . This change represents an update in the estimated study completion date for the clinical trial involving combination therapy with various drugs in patients with advanced or metastatic cancer.
    Difference
    0.0%
    Check dated 2024-05-31T10:33:43.000Z thumbnail image
  8. Check
    17 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 02 22 04 22 02 20 02 22 02 to 05 29 08 30 05 27 (Estimated) 05 29 05. This change likely represents an update in the study completion date from 2024-08-30 to 2024-05-29, indicating a potential advancement in the timeline for the study related to Niraparib, TSR-022, Bevacizumab, and Platinum-Based Doublet Chemotherapy in Combination With TSR-042.
    Difference
    0.7%
    Check dated 2024-05-30T09:33:01.000Z thumbnail image
  9. Check
    24 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to include detailed eligibility criteria for patients with advanced or metastatic cancer, specifying inclusion and exclusion criteria for different parts of the study. Previously, no information was provided in this section.
    Difference
    50%
    Check dated 2024-05-22T21:23:57.000Z thumbnail image
  10. Check
    46 days ago
    Change Detected
    Difference
    0.7%
    Check dated 2024-04-30T22:39:09.000Z thumbnail image

Stay in the know with updates to Niraparib Combo With TSR-042 in Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Niraparib Combo With TSR-042 in Ovarian Cancer Clinical Trial page.